Search Technologies

Showing 1-3 of 3 results found

New Insect Sf9-ET Cell Line for Determining Baculovirus Titers

The National Cancer Institute (NCI) seeks licensing partners for a novel modified insect cell line, Sf9-ET, that can quickly and efficiently determine baculovirus titers during the expression of recombinant proteins from a baculovirus-based protein expression system.

Research Tools

Tni-FNL: An Improved Trichoplusia Ni Cell Line for Protein Expression

Researchers at the National Cancer Institute (NCI) seek licensing for an improved cell line called Tni-FNL which is capable of high level expression of heterologous proteins using baculovirus expression systems.

Research Tools

Bac-2-the-Future: An Improved System for Production of Recombinant Baculovirus

The National Cancer Institute (NCI) seeks licensing of Bac-2-the-Future, an improved system for the production of recombinant baculovirus.

Research Tools

You are here

Product Type

Development Stage

Therapeutic Area

Institutes and Centers

Search Technologies

New Insect Sf9-ET Cell Line for Determining Baculovirus Titers

Tni-FNL: An Improved Trichoplusia Ni Cell Line for Protein Expression

Bac-2-the-Future: An Improved System for Production of Recombinant Baculovirus